- BraVoCycles Newsletter
- Posts
- NVDA Topped?
NVDA Topped?
Magnificent 7 Continued
Hey Market Timer!
Get Ahead of the Stock Market.
“Listen” to what a respected Twitter analyst and poster said:
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/6ee199a3-525d-4c7c-b5cb-3a70ba139c33/image.png?t=1714915365)
Hey, that’s me, BraVoCycles. 😊 In the premium newsletters, I cover everything you need to know about the stock market. Unleash the power of market timing. Upgrade now!
Before we get into it, Thank You for your responsiveness to our sponsors’ and partner ads, it greatly helps us publish this newsletter for free.
Today we have a message from: Hims
Effective hair loss solutions doctors trust
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/25900145-a47d-4696-a6a9-1f132482b346/image.png?t=1721328120)
Hims knows the hair loss struggle is real. That’s why they offer access to a variety of hair loss treatments for men with doctor-trusted ingredients (and have the 5-star reviews to back them up!).
Dealing with a receding hairline, bald spots, or all-over thinning? Hims has a solution that can help you start regrowing your hair in just 3-6 months**.
Start your hair regrowth journey today. After completing an intake form, a licensed medical provider will review and determine if a prescription is appropriate. If prescribed, your medication ships for free!
No doctor visits, no boring waiting rooms, and no never-ending pharmacy lines.
Try their hair loss treatments for men today (and save when you subscribe).***
*Hair Hybrids are compounded products and have not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs. Restrictions apply, see website for full details. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. **Based on separate individual studies of oral minoxidil and oral finasteride. ***Actual price to customer will depend on product and subscription plan purchased.
NVDA Update
We looked at NVDA 1-2 months ago.
After the initial sharp drop, NVDA had a nice bounce almost to the all-time highs, which appears to be corrective so far. Then it turned down again.
The daily cycle composite generally points down into early 2025, with bounces along the way.
NVDA is key for the Semiconductor Index, but also for NDX. I will be watching it.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/418e0589-cc8c-4feb-b594-52922c57ffc6/image.png?t=1721327335)
Subscriber’s Request – Opportunities?
A subscriber requested a cycle evaluation of Kering SA (KER.PA), a French fashion company, and Solana.
I encourage others to suggest companies with interesting potential. Together, we can find more opportunities. However, not all stocks are amenable to cycle analysis.
Looking at the LT chart and technical indicators, the next chart below looks like KER.PA is completing a. . .
To continue reading about this opportunity, upgrade to Full Premium- Pro today. . .
Can’t get enough of high quality newsletters?
Subscribe to these #FREE #newsletters. Just click the images below. This greatly helps to publish our free newsletter.
![](https://media.beehiiv.com/cdn-cgi/image/format=auto,onerror=redirect/uploads/publication/logo/027aa3fe-919d-491c-8e24-caf569b61ebb/thumb_BraVo_Photo_IMG_3412-1-gigapixel-standard-width-400px-cropped__1_.png)
Subscribe to Pro to read the rest.
Become a paying subscriber of Pro to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In
Reply